COVID-19 Pneumonia in a Pediatric Sickle Cell Patient Requiring Red Blood Cell Exchange

Overview

Journal Clin Case Rep

Date 2021 Mar 26

PMID 33768846

Citations 2

Authors

Shannon C Walker

Meghan L Murphy

Hope Hendricks

Daniel E Dulek

Emmanuel J Volanakis

Scott C Borinstein

Affiliations

Soon will be listed here.

Abstract

Patients with sickle cell disease are already at high risk for respiratory complications, which SARS-CoV-2 can rapidly worsen. The case emphasizes the importance of efficiently maximizing standard therapies in sickle cell patients with COVID-19.

Citing Articles

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.

Hoogenboom W, Alamuri T, McMahon D, Balanchivadze N, Dabak V, Mitchell W Blood Rev. 2021; 53:100911.

PMID: 34838342 PMC: 8605823. DOI: 10.1016/j.blre.2021.100911.

COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange.

Walker S, Murphy M, Hendricks H, Dulek D, Volanakis E, Borinstein S Clin Case Rep. 2021; 9(3):1367-1370.

PMID: 33768846 PMC: 7981740. DOI: 10.1002/ccr3.3774.

References

Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

Johnson R, Vinetz J . Dexamethasone in the management of covid -19. BMJ. 2020; 370:m2648. DOI: 10.1136/bmj.m2648. View

Beerkens F, John M, Puliafito B, Corbett V, Edwards C, Tremblay D . COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient. Am J Hematol. 2020; 95(7):E154-E156. DOI: 10.1002/ajh.25809. View

Heilbronner C, Berteloot L, Tremolieres P, Dupic L, de Saint Blanquat L, Lesage F . Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit. Br J Haematol. 2020; 190(1):e21-e24. PMC: 7276717. DOI: 10.1111/bjh.16802. View

Sahu K, Siddiqui A, cerny J . Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020; 190(2):e86-e89. PMC: 7283851. DOI: 10.1111/bjh.16880. View

Darbari D, Fasano R, Minniti C, Castro O, Gordeuk V, Taylor 6th J . Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell Disease. J Natl Med Assoc. 2017; 100(8):948-951. PMC: 5577928. DOI: 10.1016/S0027-9684(15)31410-3. View

Beigel J, Tomashek K, Dodd L, Mehta A, Zingman B, Kalil A . Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020; 383(19):1813-1826. PMC: 7262788. DOI: 10.1056/NEJMoa2007764. View

Walker S, Murphy M, Hendricks H, Dulek D, Volanakis E, Borinstein S . COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange. Clin Case Rep. 2021; 9(3):1367-1370. PMC: 7981740. DOI: 10.1002/ccr3.3774. View

Noubiap J, Temgoua M, Tankeu R, Tochie J, Wonkam A, Bigna J . Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thromb J. 2018; 16:27. PMC: 6171302. DOI: 10.1186/s12959-018-0179-z. View

10.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X . High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020; 46(6):1089-1098. PMC: 7197634. DOI: 10.1007/s00134-020-06062-x. View

11.

Appiah-Kubi A, Acharya S, Fein Levy C, Vlachos A, Ostovar G, Murphy K . Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases. Br J Haematol. 2020; 190(4):e221-e224. PMC: 7405127. DOI: 10.1111/bjh.17013. View

12.

Griffin T, McIntire D, Buchanan G . High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med. 1994; 330(11):733-7. DOI: 10.1056/NEJM199403173301101. View